2016 annual financial data
XTL Biopharmaceuticals 2016 Operating margin
Direct answer
Operating margin was -11,134.78%.
Operating income was -2,561,000 USD and net income was -2,545,000 USD.
Operating cash flow was -1,732,000 USD.
Get free XTL Biopharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 23,000 USD
- Operating income
- -2,561,000 USD
- Net income
- -2,545,000 USD
- Operating cash flow
- -1,732,000 USD